Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.
Who will be affected?
Readers: No access to all 28 journals. We recommend accessing our articles via PubMed Central
Authors: No access to the submission form or your user account.
Reviewers: No access to your user account. Please download manuscripts you are reviewing for offline reading before Wednesday, July 01, 2020 at 7:00 PM.
Editors: No access to your user account to assign reviewers or make decisions.
Copyeditors: No access to user account. Please download manuscripts you are copyediting before Wednesday, July 01, 2020 at 7:00 PM.
Jones K, White G, Bennett A, Bulls H, Escott P, Orris S, Escott E, Fischer S, Hamm M, Krishnamurti T, Wong R, LeBlanc T, Liebschutz J, Meghani S, Smith C, Temel J, Ritchie C, Merlin J
Benefits, Harms, and Stakeholder Perspectives Regarding Opioid Therapy for Pain in Individuals With Metastatic Cancer: Protocol for a Descriptive Cohort Study
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Opioid therapy for pain in individuals with metastatic cancer: benefits, harms, and stakeholder perspectives: A Protocol Paper
Katie Jones;
Gretchen White;
Antonia Bennett;
Hailey Bulls;
Paula Escott;
Sarah Orris;
Elizabeth Escott;
Stacey Fischer;
Megan Hamm;
Tamar Krishnamurti;
Risa Wong;
Thomas LeBlanc;
Jane Liebschutz;
Salimah Meghani;
Cardinale Smith;
Jennifer Temel;
Christine Ritchie;
Jessica Merlin
ABSTRACT
Background:
Opioids are a key component of pain management among patients with metastatic cancer pain. However, the evidence base available to guide opioid-related decision-making in individuals with advanced cancer is limited.
Objective:
This manuscript outlines the protocol the “Opioid therapy for pain in individuals with metastatic cancer: The BEnefits, harms, and STakeholder perspectives (BEST) study”.
Methods:
This is a multicenter, prospective cohort study that aims to enroll 630 patients with advanced cancer, 20 care partners, and 20 clinicians (670 total participants).
Results:
The data collection is underway at four clinical sites and results will be reported in future manuscripts.
Conclusions:
Upon successful execution of our study protocol, we anticipate the development of a comprehensive evidence-base on opioid therapy in individuals with advanced cancer guided by the Behavioral Decision Research framework. Clinical Trial: N/a
Citation
Please cite as:
Jones K, White G, Bennett A, Bulls H, Escott P, Orris S, Escott E, Fischer S, Hamm M, Krishnamurti T, Wong R, LeBlanc T, Liebschutz J, Meghani S, Smith C, Temel J, Ritchie C, Merlin J
Benefits, Harms, and Stakeholder Perspectives Regarding Opioid Therapy for Pain in Individuals With Metastatic Cancer: Protocol for a Descriptive Cohort Study
